Stay updated on Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page, indicating a new version of the document. This appears to be an administrative update with no visible changes to the study details or data presented.
    Difference
    0.0%
    Check dated 2026-05-15T06:01:12.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The record page reflects a newer update timestamp/version and expands the listed study sites by adding additional participating hospitals in Japan and China, increasing the total number of locations from 80 to 86. Other displayed changes are version/date-related rather than changes to trial design or key clinical details.
    Difference
    0.6%
    Check dated 2026-04-24T05:58:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:29:35.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0. It seems to be an internal version update rather than a modification to visible page content.
    Difference
    0.0%
    Check dated 2026-03-19T04:51:55.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Added two new study sites: National and Kapodistrian University of Athens – School of Health Sciences – Faculty of Medicine (Athens, Greece) and Shanghai Jiao Tong University School of Medicine – Renji Hospital (Shanghai, China). Total number of locations updated to 80.
    Difference
    0.3%
    Check dated 2026-03-12T02:38:43.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    New study sites were added, including Universitaetsklinikum Hamburg-Eppendorf (Hamburg, Germany), Sichuan Provincial Academy of Medical Sciences and Sichuan Provincial People’s Hospital (Chengdu, China), Peking Union Medical College Hospital (Beijing, China), Multiprofile hospital for active treatment Kaspela EOOD (Plovdiv, Bulgaria), and University of North Carolina School of Medicine (Chapel Hill, NC). The total number of locations is now 78.
    Difference
    0.9%
    Check dated 2026-02-11T12:47:19.000Z thumbnail image

Stay in the know with updates to Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod SubQ in Idiopathic Inflammatory Myopathy Clinical Trial page.